Hims(US:HIMS) Forbesยท2025-10-30 18:30Core Viewpoint - Hims & Hers Health (HIMS) shares are experiencing a decline, with a 2.4% drop to $45.53, as investors await the third quarter results on November 3. The stock has seen a pullback from a February high of $72.98, approaching a historically bullish trendline, indicating a potential short-term bounce [1]. Group 1: Stock Performance and Trends - The stock is currently within 0.75 of the 200-day moving average's 20-day average true range (ATR), having spent over 80% of the last 10 days above this trendline. Historically, similar conditions have led to a 18.2% average gain one month later, suggesting a potential rise to approximately $51.45 [2]. - Hims & Hers has a mixed history of post-earnings stock movements, with the stock finishing lower after four of the last eight earnings reports, including a 12.4% drop in August. The average next-day swing has been 13.3%, while this time investors are anticipating a higher move of 17.1% [3]. Group 2: Analyst Sentiment and Volatility - Analyst sentiment is predominantly negative, with 11 out of 14 analysts rating the stock as "hold" or worse, indicating potential for upgrades if bearish sentiment shifts [4]. - Hims & Hers tends to outperform options traders' volatility expectations, reflected in a Schaeffer's Volatility Scorecard (SVS) of 80 out of 100, which is favorable for prospective buyers [4].